MedPath

Correlation Between Oocyte and Embryo Mechanical Properties on Embryo Development and Clinical Pregnancy After In Vitro Fertilization

Completed
Conditions
Infertility
Pregnancy, Multiple
Interventions
Procedure: EmbryoHug
Registration Number
NCT02530892
Lead Sponsor
Stanford University
Brief Summary

The purpose of this study is to determine whether oocyte and embryo mechanical properties measured during in vitro fertilization can predict embryo development outcomes and clinical pregnancy.

Detailed Description

In the current practice of in vitro fertilization (IVF), clinicians often transfer multiple embryos to the patient at once in an effort to maximize chances of pregnancy. This practice results in a high rate of multiple births which increase the risks of complications for mothers and children.

The investigators in this study have developed a novel, noninvasive marker of embryo viability which is based on measuring embryo mechanical properties at the oocyte or the 1-cell stage. The investigators would like to test whether human oocyte or embryo mechanical properties are predictive of subsequent development, clinical pregnancy, and compare their predictive power to that of a morphological assessment (the current gold standard). Using this approach, clinicians could more confidently move toward single embryo transfer, provided more individualized counseling for patients undergoing oocyte cryopreservation, as well as improve pregnancy rates after IVF.

This is a pilot observational study. Although investigators will measure the mechanical properties of all participant oocytes and embryos, no prediction of embryo viability will be made, and there will be no intervention in choosing which embryos to transfer to participants. The data from this study will eventually be used to find a range of oocyte and embryo mechanical parameters which are predictive of high developmental potential, and will serve as the basis for an interventional study in the future.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
119
Inclusion Criteria
  • Between the ages of 21 and 45
  • Undergoing intra-cytoplasmic sperm injection (ICSI) at Stanford Fertility, Shenzhen IVF clinic, or Taiwan IVF group between August 2015 and August 2018
Read More
Exclusion Criteria
  • Using gestational carrier or donor eggs
  • Using cryopreserved eggs
  • Fewer than 5 oocytes collected
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Measurement GroupEmbryoHugThis group contains oocytes and embryos which have their mechanical properties (elasticity and viscosity) measured prior to fertilization (oocytes) or within 24 hours after fertilization (embryos). The investigators are calling this mechanical measurement the "EmbryoHug." All participants in the study will have half their embryos measured in this group. Outcomes will be evaluated after 6 days of embryo culture, at the time of pregnancy test, at 5-6 weeks, and at 8-10 weeks, and correlated with EmbryoHug parameters.
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy (8-10 weeks)8-10 weeks

Positive result is determined by presence of intrauterine gestational sac and fetal heartbeat. Outcome will record number of gestational sacs with heartbeat present.

Secondary Outcome Measures
NameTimeMethod
Blastocyst grade (Gardner scale)5-6 days

If the embryo reaches the blastocyst stage, its inner cell mass and trophectoderm will be graded according to Gardner's criteria. If no blastocyst is formed, that will be recorded as well.

Pregnancy test result (based on human chorionic gonadotropin (hCG) levels)2-3 weeks

Outcome will be recorded as either positive or negative.

Clinical pregnancy (5-6 weeks)5-6 weeks

Positive result is determined by presence of intrauterine gestational sac and fetal heartbeat (although sometimes the heartbeat does not show up for another week or two). Outcome will record number of gestational sacs.

Fertilization rate1 day

For oocytes measured, the fertilization of oocytes will be recorded.

Day 3 morphology3 days

For oocytes measured, the day 3 morphology of embryos will be recorded.

Trial Locations

Locations (3)

Taiwan IVF Group

πŸ‡¨πŸ‡³

Hsinchu, Taiwan

Stanford University IVF clinic

πŸ‡ΊπŸ‡Έ

Stanford, California, United States

Shenzhen Army and Police Hospital--Reproductive Unit

πŸ‡¨πŸ‡³

Shenzhen, China

Β© Copyright 2025. All Rights Reserved by MedPath